Okairos Company
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy.
The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Employee Number:
1-10
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2007-01-01
Industry:
Vaccines & Immunotherapy
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41 61 270 35 35
Investors:
BioMedPartners, Boehringer Ingelheim Venture Fund, EQT Life Sciences, Novartis Venture Fund, Versant Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca